Kieran Rooney
Corporate Officer/Principal presso Amakem NV
Profilo
Kieran Francis Rooney was the founder of Halo Bioconsulting Ltd.
founded in 2007, where he held the title of Managing Director.
Currently, he is the Vice President-Business Development at Amakem NV since 2013.
Dr. Rooney's former positions include being a Principal at Pharsight Corp., Pharmaceutical Profiles Group Ltd., F2G Ltd., and MDS Pharma Services (US), Inc. He was also the Vice President-Strategic Alliances & Licensing at Amryt Pharma Holdings Ltd.
Dr. Rooney's education includes an undergraduate degree from the University of Sunderland and a doctorate from The University of Wales.
Posizioni attive di Kieran Rooney
Società | Posizione | Inizio |
---|---|---|
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Corporate Officer/Principal | 24/06/2013 |
Precedenti posizioni note di Kieran Rooney
Società | Posizione | Fine |
---|---|---|
Halo Bioconsulting Ltd. | Fondatore | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
MDS Pharma Services (US), Inc. | Corporate Officer/Principal | - |
Pharmaceutical Profiles Group Ltd.
Pharmaceutical Profiles Group Ltd. Pharmaceuticals: MajorHealth Technology Pharmaceutical Profiles Ltd. develops drugs for pharmaceutical and biotech companies. The company studies how drugs are absorbed and processed in the human body. It utilizes gamma camera imaging products in its studies. It also provides complete scientific, regulatory and medical support for its client's clinical development programs. Pharmaceutical Profiles was founded in 1990 and is headquartered in Nottingham, UK. | Corporate Officer/Principal | - |
Pharsight Corp.
Pharsight Corp. Packaged SoftwareTechnology Services Pharsight's products and services help drugmakers build and shape their pipelines and decrease time and money spent on development. Using computer simulation, statistics, and data analysis along with pharmacology, disease and drug modeling, genetics, and databases of biologic information, Pharsight helps clients determine drug-development targets. | Corporate Officer/Principal | - |
Formazione di Kieran Rooney
University of Sunderland | Undergraduate Degree |
The University of Wales | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 7 |
---|---|
Pharsight Corp.
Pharsight Corp. Packaged SoftwareTechnology Services Pharsight's products and services help drugmakers build and shape their pipelines and decrease time and money spent on development. Using computer simulation, statistics, and data analysis along with pharmacology, disease and drug modeling, genetics, and databases of biologic information, Pharsight helps clients determine drug-development targets. | Technology Services |
Pharmaceutical Profiles Group Ltd.
Pharmaceutical Profiles Group Ltd. Pharmaceuticals: MajorHealth Technology Pharmaceutical Profiles Ltd. develops drugs for pharmaceutical and biotech companies. The company studies how drugs are absorbed and processed in the human body. It utilizes gamma camera imaging products in its studies. It also provides complete scientific, regulatory and medical support for its client's clinical development programs. Pharmaceutical Profiles was founded in 1990 and is headquartered in Nottingham, UK. | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom. | Health Technology |
MDS Pharma Services (US), Inc. | |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Amakem NV operates as a biopharmaceutical company. It uses kinase inhibitors for treatments of bowel, eye, and lung diseases. The company was founded by Jack Elands, Dirk Leysen, Olivier Raynald Defert, and Nadya Kaval on July 22, 2009 and is headquartered in Diepenbeek, Belgium. | Health Services |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Halo Bioconsulting Ltd. |
- Borsa valori
- Insiders
- Kieran Rooney